红花黄色素对急性脑梗死患者血清SOD、MDA、CAT影
响的临床研究
史德海;张卉田;赵梦杨;贺磊;孙乾;谭建伟;孙光印
【期刊名称】《中国实用医刊》 【年(卷),期】2011(038)008
【摘要】目的 探讨红花黄色素对急性脑梗死患者血清SOD、MDA、CAT的影响.方法 选择我院2007年11月至2009年11月急性脑梗死患者121例,随机分为观察组和对照组两组.对照组患者行常规治疗.观察组在常规治疗基础上给予红花黄色素冻干粉100 mg,每天1次.两组患者均治疗14 d.采用中国卒中量表(CSS)和美国国立卫生研究院卒中量表(NIHSS)对两组患者治疗前、治疗后进行评分.测定患者治疗前、治疗后的血清SOD、MDA、CAT水平.治疗后并对两组患者进行疗效评定.结果 ①NIHSS和CSS评分:观察组治疗后与对照组治疗后比较,差异有统计学意义(P＜0.05).②两组患者显效率比较,差异有统计学意义(P＜0.05).③SOD、MDA、CAT水平:观察组治疗后与对照组治疗后比较,差异有统计学意义(P＜0.05).结论 红花黄色素能够显著抑制急性脑梗死患者脂质过氧化反应,提高抗氧化能力,减轻脑组织氧化损伤,改善患者的神经功能.%Objective To explore the effect of safflower yellow pigment on serum level of SOD,MDA and CAT in acute cerebral infarction.Methods One hundred and twenty-one cases of acute cerebral infarction were selected from November 2007 to November 2009,and were randomly divided into observation group and control group.The routine therapy was used in control group,and on the basis of the routine therapy,safflower yellow
pigment lyophilized powder(100 mg) was used in observation group,one time in a day.The course in two groups was 14 days.Before and after treatment,Chinese stroke scale(CSS)and the National Institutes of Health Stroke Scale (NIHSS) was performed to detect the neurologic impairment.The level of SOD,MDA,CAT were detected before and after treatment.the clinical efficacy was evaluated after treatment.Results ① the score of CSS and NIHSS in observation group after treatment compared with those in control group after treatment,there was statistical difference(P<0.05).②The obvious effective rate in observation group compared with that in control group,there was statistical difference(P＜0.05).③the level of SOD,MDA,CAT in observation after treatment compared with those in control group after treatment respectively,there
was
statistical
difference(P<0.05).Conclusions
Safflower yellow pigment can inhabit lipid peroxidation in acute cerebral infarction.And improve the ability of antioxidation,decrease the brain tissue injury,improve the neurologic impairment. 【总页数】3页(48-50)
【关键词】脑梗死;氧化损伤;红花黄色素
【作者】史德海;张卉田;赵梦杨;贺磊;孙乾;谭建伟;孙光印
【作者单位】477150,河南省郸城县人民医院神经内科;477150,河南省郸城县人民医院神经内科;477150,河南省郸城县人民医院神经内科;477150,河南省郸城县人民医院神经内科;477150,河南省郸城县人民医院神经内科;477150,河南
省郸城县人民医院神经内科;477150,河南省郸城县人民医院神经内科 【正文语种】中文 【中图分类】 【文献来源】
https://www.zhangqiaokeyan.com/academic-journal-cn_chinese-journal-practical-medicine_thesis/0201255372673.html 【相关文献】
1.红花黄色素对急性脑梗死患者血浆内皮素的影响 [J], 耿昌; 赵丽军; 石春燕 2.红花黄色素注射液对急性脑梗死患者血液流变学和高敏C反应蛋白的影响 [J], 吕艳英
3.红花黄色素对老年急性脑梗死患者Tp e/QT比值的影响 [J], 刘国勇; 马宇凌; 张俊霞; 苏晓灵; 李卫; 常荣
4.羟基红花黄色素A对急性脑梗死患者血浆BNP的影响 [J], 王英; 张菊华; 梁辉; 于群涛; 邵鹏; 王敏; 闫志慧; 张慧娟
5.红花黄色素对急性脑梗死患者血清ET-1、TXB2浓度的影响分析 [J], 蔡霞; 刘建宏; 贾爱芹; 张淑芳
以上内容为文献基本信息，获取文献全文请下载
红花黄色素对急性脑梗死患者血清SOD、MDA、CAT影响的临床研究
